Sign In
|
Register
|
About Walnut Creek Guide
|
Contact Us
Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast
|
Traffic
Walnut Creek Guide News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Walnut Creek Guide Gas Prices
Ski And Snow Reports
Financial Markets
American
Bakery
Brew Pubs
Coffee Houses
Eating Places
Fast Food
German
Greek
Hawaiian
Italian
Jewish
Latin American
Lebanese
Mediterranean
Pizza
Seafood
Soul Food
Sports Bars
Steaks, Chops
Thai
Wine
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Attractions
Museums
Nightlife
Family Activities
Arts & Culture
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Vacation Rentals
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Museums
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Senior Citizen Services
Attractions & Entertainment
Air Tours
Amusement & Water Parks
Galleries
General Attractions
Jeep & Hummer Tours
Movie Theatres
Museums
Parks & Preserves
Theatre
Tours
ATV & Hummer Tours
Automotive
Auto Detail
Auto Rental
Car Washes
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Motorcycles
Parking & Storage
Parts & Supplies
Repair & Service
Beauty & Fitness
Barbers
Beauty Salons
Dance Clubs & Studios
Fitness Programs
Health Clubs & Gyms
Massage
Weight Loss
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Cemeteries & Funeral Services
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Data Processing Service
Durable Goods
Employment Services, Placement & Agencies
Energy Services
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Human Resource Services
Industrial
Internet Services
Management Services
Marketing & Advertising Services
Media Services
Office Furniture, Equipment & Supplies
Office Machines & Service
Office Supplies
Payroll Services
Photography
Printing & Publishing
Public Relations & Publicity
Research
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Telecommunications
Trucking & Hauling
Video Production
Waste Management & Recycling
Wholesale
Commercial Contractors
Concierge & Lifestyle Services
Contractors
Air Conditioning
Architects
Building Contractors & Consultants
Carpentry
Concrete
Drywall, Plastering & Insulation
Electric
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Painting & Wallcovering
Plumbing
Pools, Spas & Saunas
Special Trade Contractors
Domestic Services
Child Care Services
Housecleaning
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Misc. Financial Services
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
Post Offices
State Government
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Medical Equipment & Supplies
Mental Health
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Doors, Windows & Drapery
Electric
Floor Coverings
Furniture
Glass
Heating, Cooling & AC
Home Improvement Centers
Kitchen
Lamps & Lighting
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Pest Control
Plumbing
Pools, Spas & Saunas
Safety & Security
Tree Services
Water Supply
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Audio & Visual
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Health Care & Pharmaceutical
Industrial Supplies & Services
Machine Shops
Metal
Textiles & Apparel
Media
Cable & Pay TV Services
Print Publications
Television Stations
Meeting & Event Planning
Audio & Visual
Event Facilities
Exhibit Designers
Lodging
Meeting Planners
Party Rentals & Entertainment
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Personal Service
Barbers, Beauty Salons & Spas
Car Wash
Dry Cleaning and Laundry
Shoe Repair
Pets
Pet Shops
Pet Supplies & Food - Retail
Training
Veterinary Hospitals
Real Estate
Appraisers
Assisted Living & Elder Care Service
Commercial
Condominiums
Developers
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Brew Pubs
Coffee Houses
Eating Places
Fast Food
Italian
Mexican
Pizza
Seafood
Sports Bars
Steaks, Chops
Wine
Shopping
Accessories
Antiques
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Department Stores
Discount Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Gourmet & Specialty Foods
Grocery Stores
Health Food Stores
Hobbies & Crafts
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Notions
Office Supplies & Service
Pharmacies
Rental Service Stores
Repair Shops
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Boating
Camping & Parks
Dance Clubs & Studios, Instruction
Fishing, Fishing Charters and Tours
Golf Courses
Golf Equipment & Supplies
Health Clubs
Instruction
Professional Sports Teams
Recreation Facilities
Sporting Goods
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Airlines & Airports
Auto Rentals
Bus Lines & Charters
Hotels & Resorts
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Ceremony & Reception Venues
Entertainment
Florists
Health & Beauty
Photographers & Videographers
Transportation
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Walnut Creek Guide
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inhibikase Therapeutics Inc
(NQ:
IKT
)
2.780
+0.090 (+3.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Inhibikase Therapeutics Inc
Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension
October 21, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension
October 09, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
August 14, 2024
Company to host conference call on August 15, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
August 07, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease
June 17, 2024
Company expects to report trial results in 4Q24
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
June 05, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
May 20, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
May 15, 2024
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
May 15, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
May 09, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
April 18, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
April 03, 2024
Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial Hypertension
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
March 27, 2024
Company to host conference call on Thursday, March 28, 2024 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
March 07, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
February 28, 2024
Company to pursue eleven indications for IkT-001Pro; all previously approved for treatment with imatinib mesylate
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
February 07, 2024
- The Company continues to progress the 201 Trial evaluating risvodetinib in untreated Parkinson’s disease -
From
Inhibikase Therapeutics
Via
GlobeNewswire
Dr. Milton Werner, CEO of Inhibikase Therapeutics, Inc. is Featured in an Interview With SmallCapsDaily
February 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
January 29, 2024
Via
AB Newswire
Topics
Retirement
Exposures
Pension
Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
January 29, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
January 16, 2024
Joseph Frattaroli to retire at end of 1Q24; Garth Lees-Rolfe, Vice-President of Finance, to be promoted to Chief Financial Officer
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
December 19, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro
December 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
November 14, 2023
Company to host conference call on Wednesday, November 15, 2023 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment
October 16, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
October 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Including A/H Wednesday As Interest In Ikt-148009 Intensifies ($IKT)
March 16, 2023
Via
AB Newswire
Exposures
Product Safety
Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead Candidate IkT-148009 ($IKT)
March 14, 2023
Via
AB Newswire
Exposures
Product Safety
NASDAQ Co. Working Towards Advanced Treatments for Parkinson’s Disease and Cancer. Inhibikase Therapeutics (NASDAQ: IKT)
June 07, 2021
NASDAQ Company Diligently Working Towards Advanced Treatments for Parkinson’s Disease and Cancer: Inhibikase Therapeutics, Inc. (Stock Symbol: IKT)
Via
EIN Presswire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.